Leading Payer Account Trends

Leading Payer Account Trends provides insights on trends that influence key strategic activities, service offerings, drug access management, restrictions, and programs across the largest national health plans and PBMs.

Marketplace Dynamics: Autoimmune

Marketplace Dynamics: Autoimmune assesses current and future access and prescribing landscapes for autoimmune drugs, supporting identification of opportunities and risks for brands.

Marketplace Dynamics: Multiple Sclerosis

Marketplace Dynamics: Multiple Sclerosis assesses current and future access and prescribing landscapes for multiple sclerosis drugs, supporting identification of opportunities and risks for brands.

Marketplace Dynamics: Therapeutic Area of Choice

Marketplace Dynamics: Therapeutic Area of Choice assesses the current and future access and prescribing landscape for treatments to support effective identification of opportunities and risks for brands.

Medical Group Trends

Medical Group Trends provides insights into medical group activities that impact pharmaceutical product access, utilization management strategies, and engagement opportunities.

National Account Profiles

National Account Profiles provides insights on the size, structure, and business strategies of leading national healthcare organizations, wholesalers/distributors, retail and specialty pharmacies, group purchasing organizations (GPOs), and emerging competitors.

Oncology Pathways Engagement

Oncology Pathways Engagement provides insights on the evolution of oncology pathways, supporting timely, effective engagement with each stakeholder type to optimize access for branded oncology drugs.

Organized Customer Account Trends

Organized Customer Account Trends provides insights into health system activities that impact pharmaceutical product access, utilization management strategies, and engagement opportunities.

Patient Services and Hubs

Patient Services and Hubs assesses the importance/value, use, and satisfaction level of patient service programs, highlighting industry best practices and supporting company efforts to improve patient access to autoimmune, oncology, and rare disease therapies, while allowing…

Quality Performance and Priorities

Quality Performance and Priorities analyzes health plan performance across the most critical quality metrics to identify partnership opportunities that will improve outcomes and increase brand market share.‚Äč